DIABETES DEVICES AND DRUGS MARKET ANALYSIS

Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring (Blood Glucose Monitoring Devices, Software Programs for Diabetes Monitoring, Artificial Pancreas, Other Testing Devices), Therapeutics (Insulin, Insulin Delivery, Oral Hypoglycemic Agents, Cell Therapies)), By Disease Type (Type 2 Diabetes, Type 1 Diabetes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jun 2023
Code : CMI3857
Pages :210
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Diabetes Devices And Drugs Market: Key Developments

In April 2022, Ypsomed Holding, a leading developer and manufacturer of injection and infusion systems based in Switzerland, announced a partnership with Abbott, a global healthcare company, and CamDiab, a medical service company, to accelerate the development of an automated insulin delivery system for diabetics. Abbott's FreeStyle Libre 3 sensor, CamDiab's CamAPS FX algorithm, and Ypsomed's mylife YpsoPump are all part of the system.

In May 2021, Medtronic plc, a medical technology company, received CE (Conformité Européenne) Mark for its Guardian 4 sensor3, which requires no fingersticks1 for calibration or diabetes treatment decisions. The CE Mark allows this next-generation sensor to be integrated with either the MiniMed 780G insulin pump system or Medtronic.

In March 2021, EOFlow, a developer of wearable medicine delivery solutions, launched a unique wearable and disposable insulin pump in South Korea.